Dr. Susanne Arnold, MD

• Medical Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Kentucky Hospital

  Fellowship Hospital, 1998

• University Va Hospital

  Internship Hospital, 1993

• University Of Kentucky College Of Medicine

  Medical School, 1992

• Factors Predicting Participation in the Prospective Genomic Sequencing Study, Total Cancer Care (TCC), in Kentucky, 2020-07-06

• Association analysis of driver-gene related genetic variants identified novel lung cancer susceptibility loci with 20,871 lung cancer cases and 15,971 controls, 2020-04-10

• Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618, 2009-11-25

• Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy, 2017-08-30

• Evaluation of Antioxidant Network Proteins as Novel Prognostic Biomarkers for Head and Neck Cancer Patients, 2020-08-12

• Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (Onyx IST reference number: CAR-IST-553), 2017-02-16

• Publisher Correction: Shared heritability and functional enrichment across six solid cancers, 2019-09-23

• Characterization of Squamous Cell Lung Cancers from Appalachian Kentucky, 2018-10-30

• Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk, 2018-08-13

• Case report: A unique presentation of a high-grade neuroepithelial tumor with EWSR1::PATZ1 fusion with diagnostic, molecular, and therapeutic insights, 2023-01-31

• A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer, 2023-04-27

• EGFR testing and erlotinib use in non-small cell lung cancer patients in Kentucky, 2020-08-18

• Description of a Lung Cancer Hotspot: Disparities in Lung Cancer Histology, Incidence, and Survival in Kentucky and Appalachian Kentucky, 2021-03-26

• Cross-Registry Neural Domain Adaptation to Extract Mutational Test Results from Pathology Reports, 2019-08-08

• A probabilistic method for leveraging functional annotations to enhance estimation of the temporal order of pathway mutations during carcinogenesis, 2019-12-02

• Shared heritability and functional enrichment across six solid cancers, 2019-01-25

• p16INK4a Status and Response to Induction Low-Dose Fractionated Radiation in Advanced Head and Neck Cancer, 2015-03-25

• Association of first primary cancer with risk of subsequent primary cancer among survivors of adult-onset cancers in Kentucky and Appalachian Kentucky, 2023-08-17

• A Phase 1 Study of 7-t-butyldimethylsilyl-10-hydroxycamptothecin (AR-67) in Adult Patients with Refractory or Metastatic Solid Malignancies, 2010-01-12

• S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide, 2016-04-25

• A new efficient method to detect genetic interactions for lung cancer GWAS, 2020-10-30

• Responsive Hydrogel Nanoparticles for Pulmonary Delivery, 2015-10-01

• Population Pharmacokinetic Analysis of AR-67, a Lactone Stable Camptothecin Analogue, in Cancer Patients with Solid Tumors, 2019-02-28

• Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes, 2017-06-12

• Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization, 2020-09-23

• A Randomized, Phase III Study of Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab Investigating EGFR FISH in Patients with Advanced Non-Small Cell Lung Cancer: SWOG S0819, 2017-11-20

• Toxicity evaluation of magnetic hyperthermia induced by remote actuation of magnetic nanoparticles in 3D micrometastasic tumor tissue analogs for triple negative breast cancer, 2016-12-23

• A case-control study of trace-element status and lung cancer in Appalachian Kentucky, 2019-02-27

• Accuracy of Self-Reported Tobacco Assessments in a Head and Neck Cancer Treatment Population, 2011-11-25

• Immune checkpoint inhibitors in large cell neuroendocrine carcinoma: current status, 2018-02-22

• Gene-gene interaction ofAhRwith and within theWntcascade affects susceptibility to lung cancer, 2022-01-31

• Epidemiologic Analysis Along the Mevalonate Pathway Reveals Improved Cancer Survival in Patients Who Receive Statins Alone and in Combination With Bisphosphonates, 2019-04-05

• Elevated platelet count appears to be causally associated with increased risk of lung cancer: A Mendelian randomization analysis, 2019-01-30

• SDA: a semi-parametric differential abundance analysis method for metabolomics and proteomics data, 2019-10-17

• Exceptional Survival Among Kentucky Stage IV Non-small Cell Lung Cancer Patients: Appalachian Versus Non-Appalachian Populations, 2020-11-18

• Formulation and Characterization of Inhalable Magnetic Nanocomposite Microparticles (MnMs) for Targeted Pulmonary Delivery via Spray Drying, 2014-12-24

• Neoadjuvant administration of hydroxychloroquine in a phase 1 clinical trial induced plasma Par-4 levels and apoptosis in diverse tumors, 2018-05-01